Abstract

In 2016, a multicenter double-blind placebo-controlled randomized clinical trial in parallel groups was completed in the Russian Federation to evaluate the efficacy of the liquid dosage form of Anaferon for children in the treatment of acute respiratory viral infections in children. The design and main results of the study are presented in the largest foreign database ClinicalTrials. gov of the National Library of Medicine of the USA. In November 2018, the collection of reports of the XIII Russian Scientific and Practical Conference with international participation “Health is the basis of human potential: problems and solutions” published the article of the Russian chemist N.N. Khromov-Borisov, where the author questions the reliability of the study of the liquid form of Anaferon for children. The presented article analyzes the legitimacy of the author’s claims. From the point of view of statistics, the analysis of N.N. Khromov-Borisov cannot be considered objective and correct, since it contains gross methodological errors.

Highlights

  • В 2016 г. в Российской Федерации завершилось многоцентровое двойное слепое плацебо-контролируемое рандомизированное клиническое исследование в параллельных группах по оценке эффективности жидкой лекарственной формы Анаферона детского в лечении острых респираторных вирусных инфекций у детей

  • In 2016, a multicenter double-blind placebo-controlled randomized clinical trial in parallel groups was completed in the Russian Federation to evaluate the efficacy of the liquid dosage form of Anaferon for children in the treatment of acute respiratory viral infections in children

  • The design and main results of the study are presented in the largest foreign database ClinicalTrials. gov of the National Library of Medicine of the USA

Read more

Summary

Introduction

В 2016 г. в Российской Федерации завершилось многоцентровое двойное слепое плацебо-контролируемое рандомизированное клиническое исследование в параллельных группах по оценке эффективности жидкой лекарственной формы Анаферона детского в лечении острых респираторных вирусных инфекций у детей. Комплексный гармонизированный статистический анализа результатов данных о РКИ жидкой лекарственной формы Анаферона детского*» [4].

Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call